Vietnamese traditional medicine from a pharmacist's perspective

Expert Review of Clinical Pharmacology

Volumn 5, Issue 4, 2012, Pages 459-477

  Woerdenbag, Herman J ^a   Nguyen, Tuyen Manh ^b   Vu, Dien Van ^b   Tran, Hung ^c   Nguyen, Dung Tuan ^c   Tran, Thanh Van ^d   De Smet, Peter Agm ^e   Brouwers, Jacobus Rbj ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b HANOI UNIVERSITY OF PHARMACY   (Viet Nam)

^c UNIVERSITY OF MEDICINE AND PHARMACY AT HO CHI MINH CITY   (Viet Nam)

^d Ministry of Health of Vietnam   (Viet Nam)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

effectiveness; herb drug interactions; herbal drugs; safety; Vietnamese traditional medicine

Indexed keywords

(HERBA ECLIPTA EXTRACT; ABUTILI INDICI EXTRACT; ACHYRANTHES ASPERA EXTRACT; ACHYRANTHIS ASPERAE EXTRACT; ADENOSMATIS INDIANI EXTRACT; ALKALOID; CAESALPINIA SAPPAN EXTRACT; CENTELLAE ASIATICAE EXTRACT; CYNARAE SCOLYMI EXTRACT; DESMODII STYRACIFOLII EXTRACT; DRACAENAE CAMBODIANAE EXTRACT; FOLIUM ERYTHRINAE EXTRACT; HEDYOTIDIS CAPITELLATAE EXTRACT; HEDYOTIS CAPITELLATA EXTRACT; HERBA PASSIFLORAE EXTRACT; HERBACEOUS AGENT; MORINDA OFFICINALIS EXTRACT; MORINDAE OFFICINALIS EXTRACT; ORTHOSIPHONIS SPIRALIS EXTRACT; PASSIFLORA FOETIDA EXTRACT; PLANT EXTRACT; POLYGONI CUSPIDATI EXTRACT; RHIZOMA ALISMATIS EXTRACT; STEMONA TUBEROSA EXTRACT; STEMONININE; STEPHANIAE GLABRAE EXTRACT; STRYCHNINE; TUBEROSTEMONINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; WEDELIA EXTRACT;

ASTHMA; BLEEDING; CHINESE MEDICINE; COUGHING; DIARRHEA; DRUG ACTIVITY; DRUG EFFICACY; DRUG FORMULATION; DRUG LEGISLATION; EVIDENCE BASED MEDICINE; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HUMAN; MEDICAL PRACTICE; MOLECULAR BEACON; NAUSEA; NONHUMAN; PHARMACEUTICAL CARE; RASH; REVIEW; STRYCHNOS NUX VOMICA; TRADITIONAL MEDICINE; UNSPECIFIED SIDE EFFECT; VIET NAM;

ANIMALS; HERB-DRUG INTERACTIONS; HUMANS; MEDICINE, CHINESE TRADITIONAL; MEDICINE, EAST ASIAN TRADITIONAL; PHARMACEUTICAL SERVICES; PHARMACISTS; PHYTOTHERAPY; QUALITY ASSURANCE, HEALTH CARE; VIETNAM;

EID: 84866140149     PISSN: 17512433     EISSN: 17512441     Source Type: Journal    
DOI: 10.1586/ecp.12.34     Document Type: Review

References (137)

1. Nguyen S, Miller DR, Dingel MJ. Traditional medicine use in a Vietnamese-American community. Ann. Pharmacother. 44(4), 769-770 (2010).
2. O'Callaghan C, Quine S. How older Vietnamese Australian women manage their medicines. J. Cross. Cult. Gerontol. 22(4), 405-419 (2007).
3. Loi DT, Duñg NX. Native drugs of Vietnam: Which traditional and scientific approaches? J. Ethnopharmacol. 32(1-3), 51-56 (1991).
4. WHO. National policy on traditional medicine and regulation of herbal medicines. Report of a WHO global survey. Geneva, Switzerland (2005).
5. De Smet PA, Brouwers Jr. Pharmacokinetic evaluation of herbal remedies. Basic introduction, applicability, current status and regulatory needs. Clin. Pharmacokinet. 32(6), 427-436 (1997).
6. Dung TN, Bodeker G. Tue Tinh: Founder of Vietnamese traditional medicine. J. Altern. Complement. Med. 7(5), 401-403 (2001).
7. Ngoc H, Borton L. Frequently asked questions about Vietnamese culture. In: Traditional Medicine (2nd Edition). The Gioi Publishers, Hanoi, Vietnam (2008).
8. Nguyen D. Culture shock-a review of Vietnamese culture and its concepts of health and disease. West. J. Med. 142(3), 409-412 (1985).
9. Le TD. Brief History of Vietnamese Medicine and Tue Tinh's Pharmacy. Medical Publishing House, Hanoi, Vietnam 8-14
10. Chau HB. Present situation of the Vietnamese integrated medicine. Chin. J. Integrat. Med. 4, 66-71 (1998).
11. Wahlberg A. Bio-politics and the promotion of traditional herbal medicine in Vietnam. Health (London) 10(2), 123-147 (2006).
12. Banskota AH, Tezuka Y, Le Tran Q, Kadota S. Chemical constituents and biological activities of Vietnamese medicinal plants. Curr. Top. Med. Chem. 3(2), 227-248 (2003).
13. Ogle BM, Ho TT, Hoang ND, Nguyen NXD. Food, feed or medicine: The multiple functions of edible wild plants in Vietnam. Econ. Bot. 57, 103-117 (1993).
14. Anonymous. Pharmacopoeia Vietnamica (4th Edition). Ministry of Health of Vietnam, Hanoi, Vietnam (2009).
15. Nguyen VT. Traditional medicine in Vietnam. In: Oriental Medicine. Van Alphen J, Aris A (Eds). Serindia Publications, London, UK 209-215 (1995).
16. Purnell LD. Traditional Vietnamese health and healing. Urol. Nurs. 28(1), 63-67 (2008).
17. Pham XS, Phung HB. Traditional Medicine. Health Publishing House, Hanoi, Vietnam (2006).
18. Chau HB, Thuan PD, Ngoc H. Vietnamese Traditional Medicine. The Gioi Publishers, Hanoi, Vietnam (1999).
19. Wichtl M. Teedrogen und Phytopharmaka (5th Edition). Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart, Germany (2009).
20. Schilcher H, Kammerer S, Wegener T. Leitfaden Phytotherapie. (4th Edition).
21. Elsevier/Urban & Fischer Verlag, München, Germany (2010).
22. Nguyen MT. Antitussive and phlegmolytic properties of raw and traditionally processed items of Bach bo (Radix Stemonae tuberosae). Pharm. J. (Hanoi) 407, 15-18 (2010).
23. Nguyen MT, Nguyen VH, Nguyen MH. Determination of total alkaloids and tuberostemonin LG of raw and various traditionally processed items of Bach bo (Radix Stemonae tuberosae). Pharm. J. (Hanoi) 408, 20-24 (2010).
24. Hempen CH, Fischer T. Leitfaden Chinesische Phytotherapie. Urban & Fischer, München, Germany (2007).
25. WHO. Medicinal Plants from Viet Nam. WHO/WPRO, Manila, Philippines (1990).
26. Venkataramanan R, Komoroski B, Strom S. In vitro and in vivo assessment of herb drug interactions. Life Sci. 78(18), 2105-2115
27. Guidelines on the assessment of clinical safety and efficacy in the preparation of community herbal monographs for well-established and community herbal monographs/entries to the community list for traditional herbal medicinal products/substances/preparations. (EMEA/HMPC/104613/2005). Committee on Herbal Medicinal Products (HMPC), European Agency for the Evaluation of Medicinal Products, London, UK (2006).
28. Van der Kuy A, Woerdenbag HJ. Evaluation and evaluation criteria. Efficacy of phytomedicines. Pharm. Weekbl. 136, 647-650 (2001).
29. Woerdenbag HJ, Van der Meer MJ, Van der Kuy A. Levels of evidence. Therapy with phytomedicines. Pharm. Weekbl. 136, 652-657 (2001).
30. Tiwari S, Singh S, Patwardhan K, Gehlot S, Gambhir IS. Effect of Centella asiatica on mild cognitive impairment (MCI) and other common age-related clinical problems. Digest. J. Nanomat. Biostruct. 3, 215-220
31. Wang X-Q, Zhang H-Y, Shu L et al. Efficacy and safety of Morinda officinalis oligose capsule in the treatment of mild or moderate depression. Chin. J. New Drugs 18, 802-805 (2009).
32. Shaw D. Toxicological risks of Chinese herbs. Planta Med. 76(17), 2012-2018
33. De Smet PA. Health risks of herbal remedies: An update. Clin. Pharmacol. Ther. 76(1), 1-17 (2004).
34. De Smet PA. Health risks of herbal remedies. Drug Saf. 13(2), 81-93 (1995).
35. Meyler's Side Effects of Herbal Medicines. Aronson JK (Ed.). Elsevier, Amsterdam, The Netherlands (2009).
36. Vivekanand JHA. Herbal mdicines and chronic kidney disease. Nephrology 15, 10-17 (2010).
37. Parry R, Nishino S, Spain J. Naturallyoccurring nitro compounds. Nat. Prod. Rep. 28(1), 152-167 (2011).
38. Rietjens IM, Martena MJ, Boersma MG, Spiegelenberg W, Alink GM. Molecular mechanisms of toxicity of important food-borne phytotoxins. Mol. Nutr. Food Res. 49(2), 131-158 (2005).
39. Chan TY. Potential risks associated with the use of herbal anti-obesity products. Drug Saf. 32(6), 453-456 (2009).
40. Fleming RM. Safety of ephedra and related anorexic medications. Expert Opin. Drug Saf. 7(6), 749-759 (2008).
41. Cohen PA, Ernst E. Safety of herbal supplements: A guide for cardiologists. Cardiovasc. Ther. 28(4), 246-253 (2010).
42. Drew AK, Whyte IM, Bensoussan A, Dawson AH, Zhu X, Myers SP. Chinese herbal medicine toxicology database: Monograph on Herba Asari, 'xi xin'. J. Toxicol. Clin. Toxicol. 407 15-18 2010
43. Van den Berg SJPL, Restani P, Boersma MG, Delmulle L, Rietjens IMCM. Levels of genotoxic and carcinogenic compounds in plant food supplements and associated risk assessment. Food Nutrit. Sci. 2, 989-1010
44. Chen C, Spriano D, Lehmann T, Meier B. Reduction of safrole and methyleugenol in Asari radix et rhizoma by decoction. Forsch. Komplementmed. 16(3), 162-166 (2009).
45. Hänsel R, Sticher O. Pharmakognosie - Phytopharmazie. Springer Medizin Verlag, Heidelberg, Germany (2007).
46. Woerdenbag HJ, De Smet PAGM. Adverse effects and toxicity of Ginkgo extracts. In: Ginkgo biloba. Medicinal and Aromatic Plants - Industrial Profiles. van Beek TA (Ed.). Harwood Academic Publishers, Amsterdam, The Netherlands 443-452 (2000).
47. Borrelli F, Ernst E. Black cohosh (Cimicifuga racemosa): A systematic review of adverse events. Am. J. Obstet. Gynecol. 199(5), 455-466 (2008).
48. Mahady GB, Low Dog T, Barrett ML et al. United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity. Menopause 15(4 Pt 1), 628-638 (2008).
49. Teschke R. Black cohosh and suspected hepatotoxicity: Inconsistencies, confounding variables, and prospective use of a diagnostic causality algorithm. A critical review. Menopause 17(2), 426-440 (2010).
50. Lai CK, Chan AY. Tetrahydropalmatine poisoning: Diagnoses of nine adult overdoses based on toxicology screens by HPLC with diode-array detection and gas chromatography-mass spectrometry. Clin. Chem. 45(2), 229-236 (1999).
51. Hung TM, Na M, Dat NT et al. Cholinesterase inhibitory and anti-amnesic activity of alkaloids from Corydalis turtschaninovii. J. Ethnopharmacol. 119(1), 74-80 (2008).
52. Thuong PT, Dao TT, Pham TH et al. Crotonkinensins A and B, diterpenoids from the Vietnamese medicinal plant Croton tonkinensis. J. Nat. Prod. 72(11), 2040-2042
53. Giang PM, Son PT, Hamada Y, Otsuka H. Cytotoxic diterpenoids from Vietnamese medicinal plant Croton tonkinensis Gagnep. Chem. Pharm. Bull. 53, 296-300 (2005).
54. Goel G, Makkar HP, Francis G, Becker K. Phorbol esters: Structure, biological activity, and toxicity in animals. Int. J. Toxicol. 26(4), 279-288 (2007).
55. Wallwey C, Li SM. Ergot alkaloids: Structure diversity, biosynthetic gene clusters and functional proof of biosynthetic genes. Nat. Prod. Rep. 28(3), 496-510 (2011).
56. Lee JY, Lee JY, Yun BS, Hwang BK. Antifungal activity of beta-asarone from rhizomes of Acorus gramineus. J. Agric. Food Chem. 52(4), 776-780 (2004).
57. Gomes J, Pereira T, Vilarinho C, Duarte Mda L, Brito C. Contact dermatitis due to Centella asiatica. Contact Derm. 62(1), 54-55 (2010).
58. Gohil KJ, Patel JA, Gajjar AK. Pharmacological review on Centella asiatica: A potential herbal cure-all. Indian J. Pharm. Sci. 72(5), 546-556 (2010).
59. Millonig G, Stadlmann S, Vogel W. Herbal hepatotoxicity: Acute hepatitis caused by a Noni preparation (Morinda citrifolia). Eur. J. Gastroenterol. Hepatol. 17(4), 445-447
60. Stadlbauer V, Weiss S, Payer F, Stauber RE. Herbal does not at all mean innocuous: The sixth case of hepatotoxicity associated with Morinda citrifolia (Noni). Am. J. Gastroenterol. 103(9), 2406-2407 (2008).
61. Mueller BA, Scott MK, Sowinski KM, Prag KA. Noni juice (Morinda citrifolia): Hidden potential for hyperkalemia? Am. J. Kidney Dis. 35(2), 310-312 (2000).
62. Horsfall AU, Olabiyi O, Aiyegbusi A, Noronha CC, Okanlawon AO. Morinda citrifolia fruit juice augments insulin action in Sprague-Dawley rats with experimentally induced diabetes. Nig. Q. J. Hosp. Med. 18(3), 162-165 (2008).
63. Nayak BS, Marshall JR, Isitor G, Adogwa A. Hypoglycemic and hepatoprotective activity of fermented fruit fuice of Morinda citrifolia (Noni) in diabetic rats. Evid. Bas. Complement. Alt. Med. doi:10.1155/2011/875293 (2011
64. Müller-Waldeck F, Sitzmann J, Schnitzler WH, Grassmann J. Determination of toxic perilla ketone, secondary plant metabolites and antioxidative capacity in five Perilla frutescens L. varieties. Food Chem. Toxicol. 48(1), 264-270 (2010).
65. Bel-Kassaoui H, Lamnaouer D, Jossang A, Abdennebi el H, Charrouf Z, Bodo B. Role of hypaphorine in the toxicity of Astragalus lusitanicus. Nat. Prod. Res. 22(5), 453-457
66. Olukoga A, Donaldson D. Liquorice and its health implications. J. R. Soc. Promot. Health 120(2), 83-89 (2000).
67. Han ST, Un CC. Cardiac toxicity caused by Achyranthes aspera. Vet. Hum. Toxicol. 45(4), 212-213 (2003).
68. Broussard CS, Louik C, Honein MA, Mitchell AA. National Birth Defects Prevention Study. Herbal use before and during pregnancy. Am. J. Obstet. Gynecol. 202(5), 443.e1-443.e6 (2010).
69. Hall HG, Griffiths DL, McKenna LG. The use of complementary and alternative medicine by pregnant women: A literature review. Midwifery 27(6), 817-824 (2011).
70. Louik C, Gardiner P, Kelley K, Mitchell AA. Use of herbal treatments in pregnancy. Am. J. Obstet. Gynecol. 202(5), 439.e1-439.e10
71. Lin XL, Lin N, Liu CF et al. Investigation of Coptis chinensis on jaundice of glucose-6-phosphate dehydrogenase (G6PD) deficient neonates from Guigang, Guangxi province. China J. Chin. Mat. Med. 32, 2543-2546 (2007).
72. Yeung CY, Lee FT, Wong HN. Effect of a popular Chinese herb on neonatal bilirubin protein binding. Biol. Neonate 58(2), 98-103 (1990).
73. Chan E. Displacement of bilirubin from albumin by berberine. Biol. Neonate 63(4), 201-208 (1993).
74. Li N, Qin LP, Han T, Wu YB, Zhang QY, Zhang H. Inhibitory effects of Morinda officinalis extract on bone loss in ovariectomized rats. Molecules 14(6), 2049-2061 (2009).
75. Youns M, Hoheisel JD, Efferth T. Toxicogenomics for the prediction of toxicity related to herbs from traditional Chinese medicine. Planta Med. 76(17), 2019-2025 (2010).
76. De Smet PA. Clinical risk management of herb-drug interactions. Br. J. Clin. Pharmacol. 63(3), 258-267 (2007).
77. De Smet PA, Floor-Schreudering A, Bouvy ML, Wensing M. Clinical risk management of interactions between natural products and drugs. Curr. Drug Metab. 9(10), 1055-1062 (2008).
78. Zhou S, Lim LY, Chowbay B. Herbal modulation of P-glycoprotein. Drug Metab. Rev. 36(1), 57-104 (2004).
79. Na DH, Ji HY, Park EJ, Kim MS, Liu KH, Lee HS. Evaluation of metabolism-mediated herb-drug interactions. Arch. Pharm. Res. 34(11), 1829-1842 (2011).
80. Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs: An updated systematic review. Drugs 69(13), 1777-1798 (2009).
81. Kennedy DA, Seely D. Clinically based evidence of drug-herb interactions: A systematic review. Expert Opin. Drug Saf. 9(1), 79-124 (2010).
82. Tomlinson B, Hu M, Lee VW. In vivo assessment of herb-drug interactions: Possible utility of a pharmacogenetic approach? Mol. Nutr. Food Res. 52(7), 799-809 (2008).
83. Kim RB. Drugs as P-glycoprotein substrates, inhibitors, and inducers. Drug Metab. Rev. 34(1-2), 47-54 (2002).
84. Tarirai C, Viljoen AM, Hamman JH. Herb-drug pharmacokinetic interactions reviewed. Expert Opin. Drug Metab. Toxicol. 6(12), 1515-1538 (2010).
85. Haller CA, Jacob P 3rd, Benowitz NL. Pharmacology of ephedra alkaloids and caffeine after single-dose dietary supplement use. Clin. Pharmacol. Ther. 71(6), 421-432
86. Bhardwaj RK, Glaeser H, Becquemont L, Klotz U, Gupta SK, Fromm MF. Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4. J. Pharmacol. Exp. Ther. 302(2), 645-650
87. Najar IA, Sachin BS, Sharma SC, Satti NK, Suri KA, Johri RK. Modulation of P-glycoprotein ATPase activity by some phytoconstituents. Phytother. Res. 24(3), 454-458 (2010).
88. Wang H, Ye X, Gao Q et al. Pharmacovigilance in traditional Chinese medicine safety surveillance. Pharmacoepidemiol. Drug Saf. 18(5), 357-361 (2009).
89. Jordan SA, Cunningham DG, Marles RJ. Assessment of herbal medicinal products: Challenges, and opportunities to increase the knowledge base for safety assessment. Toxicol. Appl. Pharmacol. 243(2), 198-216
90. Tu Y. The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine. Nat. Med. 17(10), 1217-1220
91. Krisanapun C, Peungvicha P, Temsiririrkkul R, Wongkrajang Y. Aqueous extract of Abutilon indicum Sweet inhibits glucose absorption and stimulates insulin secretion in rodents. Nutr. Res. 29(8), 579-587
92. Yasmin S, Kashmiri MA, Asghar MN, Ahmad M, Mohy-ud-Din A. Antioxidant potential and radical scavenging effects of various extracts from Abutilon indicum and Abutilon muticum. Pharm. Biol. 48(3), 282-289 (2010).
93. Gaikwad SB, Mohan GK. Atibala: An overview. J. Pharm. Res. Health Care 3, 29-37 (2011).
94. Goyal BR, Goyal RK, Mehta AA. Phytopharmacology of Achyranthes aspera: A review. Pharmacogn. Rev. 1, 143-150
95. Anuja MN, Nithya RN, Rajamanickam C, Madambath I. Spermatotoxicity of a protein isolated from the root of Achyranthes aspera: A comparative study with gossypol. Contraception 82(4), 385-390 (2010).
96. Subbarayan PR, Sarkar M, Impellizzeri S et al. Anti-proliferative and anti-cancer properties of Achyranthes aspera: Specific inhibitory activity against pancreatic cancer cells. J. Ethnopharmacol. 131(1), 78-82 (2010).
97. Dey A. Achyranthes aspera L.: Phytochemical and pharmacological aspects. Int. J. Pharm. Res. Rev. Res. 9, 72-82 (2011).
98. Huong HT, Bao HV. Contribution to the study on antioxidative properties of Adenosma capitatum Benth in Vietnam. Pharm. J. (Hanoi) 10, 14-16 (2004).
99. Bhuiyan MNI, Akter F, Chowdhur JU, Begum J. Chemical constituents of essential oils from aerial parts of Adenosma capitatum and Limnophila aromatica. Banglad. J. Pharmacol. 5, 13-16 (2010).
100. Lee S, Kho Y, Min B et al. Cytotoxic triterpenoides from Alismatis Rhizoma. Arch. Pharm. Res. 24(6), 524-526 (2001).
101. Chen HW, Hsu MJ, Chien CT, Huang HC. Effect of alisol B acetate, a plant triterpene, on apoptosis in vascular smooth muscle cells and lymphocytes. Eur. J. Pharmacol. 419(2-3), 127-138 (2001).
102. Washiyama M, Sasaki Y, Hosokawa T, Nagumo S. Anti-inflammatory constituents of Sappan Lignum. Biol. Pharm. Bull. 32(5), 941-944 (2009).
103. Moon HI, Chung IM, Seo SH, Kang EY. Protective effects of 3'-deoxy-4-Omethylepisappanol from Caesalpinia sappan against glutamate-induced neurotoxicity in primary cultured rat cortical cells. Phytother. Res. 24(3), 463-465 (2010).
104. Sasaki Y, Suzuki M, Matsumoto T et al. Vasorelaxant activity of Sappan Lignum constituents and extracts on rat aorta and mesenteric artery. Biol. Pharm. Bull. 33(9), 1555-1560 (2010).
105. Wu J, Zhang M, Jia H et al. Protosappanin A induces immunosuppression of rats heart transplantation targeting T cells in grafts via NF-kappaB pathway. Naunyn Schmiedebergs Arch. Pharmacol. 381(1), 83-92 (2010).
106. Anonymous. Centella asiatica (monograph). Alt. Med. Rev. 12, 69-72 (2007).
107. Hashim P, Sidek H, Helan MH, Sabery A, Palanisamy UD, Ilham M. Triterpene composition and bioactivities of Centella asiatica. Molecules 16(2), 1310-1322
108. Nguyen XC, Chau VM, Phan VK et al. Inhibitors of osteoclast formation from rhizomes of Cibotium barometz. J. Nat. Prod. 72, 1673-1677 (2009).
109. Wu Q, Yang XW. The constituents of Cibotium barometz and their permeability in the human Caco-2 monolayer cell model. J. Ethnopharmacol. 125(3), 417-422 (2009).
110. Zhao M, Duan JA, Che CT. Isoflavanones and their O-glycosides from Desmodium styracifolium. Phytochemistry 68(10), 1471-1479 (2007).
111. Phan MG, Phan TS, Matsunami K, Otsuka H. Flavonoid compounds from Desmodium styracifolium of Vietnamese origin. Chem. Nat. Comp. 46, 797-798 (2010).
112. Luo Y, Wang H, Xu X, Mei W, Dai H. Antioxidant phenolic compounds of Dracaena cambodiana. Molecules 15(12), 8904-8914 (2010).
113. Xu M, Yang C-R, Zhang Y-J. New C27 steroidal bisdesmosides from the fresh stem of Dracaena cambodiana. Helv. Chim. Acta 93, 302-308 (2010).
114. Lee MK, Ha NR, Yang H, Sung SH, Kim GH, Kim YC. Antiproliferative activity of triterpenoids from Eclipta prostrata on hepatic stellate cells. Phytomedicine 15(9), 775-780 (2008).
115. Tewtrakul S, Subhadhirasakul S, Tansakul P, Cheenpracha S, Karalai C. Antiinflammatory constituents from Eclipta prostrata using RAW264.7 macrophage cells. Phytother Res. 25, 1313-1316 (2011).
116. Lee MK, Ha NR, Yang H, Sung SH, Kim YC. Stimulatory constituents of Eclipta prostrata on mouse osteoblast differentiation. Phytother. Res. 23(1), 129-131 (2009).
117. Kim DI, Lee SH, Hong JH et al. The butanol fraction of Eclipta prostrata (Linn) increases the formation of brain acetylcholine and decreases oxidative stress in the brain and serum of cesarean-derived rats. Nutr. Res. 30(8), 579-584 (2010).
118. Balamurugan G, Shantha A. Effect of Erythrina variegata seed extract on hyperlipidemia elicited by high-fat diet in wistar rats. J. Pharm. Bioallied Sci. 2(4), 350-355 (2010).
119. Zhang Y, Li Q, Li X, Wan HY, Wong MS. Erythrina variegata extract exerts osteoprotective effects by suppression of the process of bone resorption. Br. J. Nutr. 104(7), 965-971 (2010).
120. Ahmad R, Ali AM, Israf DA, Ismail NH, Shaari K, Lajis NH. Antioxidant, radicalscavenging, anti-inflammatory, cytotoxic and antibacterial activities of methanolic extracts of some Hedyotis species. Life Sci. 76(17), 1953-1964 (2005).
121. Li YF, Liu YQ, Yang M et al. The cytoprotective effect of inulin-type hexasaccharide extracted from Morinda officinalis on PC12 cells against the lesion induced by corticosterone. Life Sci. 75(13), 1531-1538 (2004).
122. Yang Z, Hu J, Zhao M. Isolation and quantitative determination of inulin-type oligosaccharides in roots of Morinda officinalis. Carbohydr. Polym. 83, 1997-2004
123. Nguyen XK. Liver-protectivity of the extracts from the plant Morinda sp. (Rubiaceae). Pharm. J. (Hanoi) 422, 24-27
124. Hsu CL, Hong BH, Yu YS, Yen GC. Antioxidant and anti-inflammatory effects of Orthosiphon aristatus and its bioactive compounds. J. Agric. Food Chem. 58(4), 2150-2156 (2010).
125. Nguyen NH, Huynh NT, Tran H, Ho HTD. Antioxidant and hepatoprotective effects of Orthosiphon aristatus on damaged liver of mice induced by carbon tetrachloride. J. Med. Mat. (Hanoi) 15, 157-162 (2010).
126. Dhawan K, Dhawan S, Sharma A. Passiflora: A review update. J. Ethnopharmacol. 94(1), 1-23 (2004).
127. Mohanasundari C, Natarajan D, Srinivasan K, Umamaheswari S, Ramachandran A. Antibacterial properties of Passiflora foetida L. - a common exotic medicinal plant. Afr. J. Biotechnol. 23, 2650-2653 (2007).
128. Zhang C, Wang X, Zhang X, Zhang Y, Xiao H, Liang X. Bioassay-guided separation of citreorosein and other oestrogenic compounds from Polygonum cuspidatum. Phytother. Res. 23(5), 740-741 (2009).
129. Lin HW, Sun MX, Wang YH et al. Anti-HIV activities of the compounds isolated from Polygonum cuspidatum and Polygonum multiflorum. Planta Med. 76(9), 889-892 (2010).
130. Lin YW, Yang FJ, Chen CL, Lee WT, Chen RS. Free radical scavenging activity and antiproliferative potential of Polygonum cuspidatum root extracts. J. Nat. Med. 64(2), 146-152 (2010).
131. Leu YL, Hwang TL, Hu JW, Fang JY. Anthraquinones from Polygonum cuspidatum as tyrosinase inhibitors for dermal use. Phytother. Res. 22(4), 552-556 (2008).
132. Xu YT, Shaw PC, Jiang RW, Hon PM, Chan YM, But PP. Antitussive and central respiratory depressant effects of Stemona tuberosa. J. Ethnopharmacol. 128(3), 679-684 (2010).
133. Pilli RA, Rosso GB, de Oliveira Mda C. The chemistry of Stemona alkaloids: An update. Nat. Prod. Rep. 27(12), 1908-1937 (2010).
134. Semwal DK, Badoni R, Semwal R, Kothiyal SK, Singh GJ, Rawat U. The genus Stephania (Menispermaceae): Chemical and pharmacological perspectives. J. Ethnopharmacol. 132(2), 369-383 (2010).
135. Semwal DK, Rawat U, Semwal R, Singh R, Singh GJ. Anti-hyperglycemic effect of 11-hydroxypalmatine, a palmatine derivative from Stephania glabra tubers. J. Asian Nat. Prod. Res. 12(2), 99-105 (2010).
136. Lin FM, Chen LR, Lin EH et al. Compounds from Wedelia chinensis synergistically suppress androgen activity and growth in prostate cancer cells. Carcinogenesis 28(12), 2521-2529 (2007).
137. Tsai CH, Lin FM, Yang YC et al. Herbal extract of Wedelia chinensis attenuates androgen receptor activity and orthotopic growth of prostate cancer in nude mice. Clin. Cancer Res. 15(17), 5435-5444